Sharps Technology Inc. financial data

Symbol
STSS, STSSW on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
105 Maxess Road, Ste. 124, Melville, NY
State of incorporation
NV
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 96.5 % -44.4%
Quick Ratio 50.4 % +39.6%
Debt-to-equity 69.6 % +99.9%
Return On Equity -165 % -59.7%
Return On Assets -97.1 % -27%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16.3M shares +4.23%
Common Stock, Shares, Outstanding 2.05M shares +195%
Entity Public Float 6.54M USD -14.1%
Common Stock, Value, Issued 205 USD +197%
Weighted Average Number of Shares Outstanding, Basic 1.26M shares +112%
Weighted Average Number of Shares Outstanding, Diluted 1.26M shares +112%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 2.47M USD +54%
General and Administrative Expense 7.15M USD -16%
Operating Income (Loss) -9.63M USD +4.94%
Nonoperating Income (Expense) 330K USD -1.75%
Net Income (Loss) Attributable to Parent -9.3M USD +5.54%
Earnings Per Share, Basic -7.4 USD/shares +55.4%
Earnings Per Share, Diluted -7.4 USD/shares +55.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 864K USD -71.3%
Inventory, Net 1.87M USD +9.28%
Assets, Current 3.17M USD -34.4%
Property, Plant and Equipment, Net 4.04M USD -40.9%
Intangible Assets, Net (Excluding Goodwill) 32.5K USD -38.1%
Other Assets, Noncurrent 105K USD -18.6%
Assets 7.31M USD -38%
Accounts Payable, Current 977K USD +23%
Liabilities, Current 5.19M USD +40.4%
Deferred Income Tax Liabilities, Net 132K USD -18.5%
Liabilities 5.32M USD +37.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 23.3K USD -96.1%
Retained Earnings (Accumulated Deficit) -34.4M USD -37%
Stockholders' Equity Attributable to Parent 2M USD -74.8%
Liabilities and Equity 7.31M USD -38%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.89M USD +8.4%
Net Cash Provided by (Used in) Financing Activities 3.24M USD +9865%
Net Cash Provided by (Used in) Investing Activities -2.85K USD +98.3%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 2.05M shares +195%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.85M USD -270%
Deferred Tax Assets, Valuation Allowance 8.79M USD +35.8%
Depreciation 190K USD -10.4%
Payments to Acquire Property, Plant, and Equipment 163K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -9.86M USD -4.23%
Property, Plant and Equipment, Gross 6.15M USD -23.5%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 1M shares 0%
Additional Paid in Capital 36.4M USD +12.1%
Preferred Stock, Shares Outstanding 0 shares -100%
Amortization of Intangible Assets 5.29K USD +32.9%
Share-based Payment Arrangement, Expense 512K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%